Author Seremetis S, Cepo K, Rasmussen JS, Rose TH, Søren Tamer, Porstmann T, Haaning J Date of Publication 3rd February 2021 Your browser does not support iframes, but you can visit < Back Related Resources Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-fatal Thrombotic Events Abstract Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-fatal Thrombotic Events Poster
Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-fatal Thrombotic Events Abstract
Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-fatal Thrombotic Events Poster